U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 20-26, 2019
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 20-26, 2019

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 01/23/2019
Location: Washington, DC
Subject: Healthcare Leadership Council: FDA Commissioner Priorities
FDA Participant/Group: KATHLEEN QUINN;
Non FDA Participant/Group: Government, industry, and other invited guests

Official Name: Patrizia Cavazzoni, M.D., (Acting), Deputy Director for Operations, CDER

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank, Yiannas, Deputy Commissioner for Food Policy & Response

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 01/22/2019
Location: Washington, DC
Subject: Expanded Access Summit: The Big Picture: Engaging More Patients in Clincial Development
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 01/24/2019
Location: Washington, DC
Subject: International Society for Pharmaceutical Engineering: Inaugural Pharmaceutical Regulatory Steering Group Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 01/23/2019
Location: Silver Spring, MD
Subject: Medical Device Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: George Serafin, Sharif Ambrose, Tamara Reynolds (Grant Thornton, LLP);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event

Back to Top